News

Podcast

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

Author(s):

Alexandra Gerlach, Associate Editor

Pharmacy Times attended the 2024 San Antonio Breast Cancer Symposium from December 10 to December 13.

This episode of Pharmacy Focus: Oncology Edition highlights key insights from the 2024 San Antonio Breast Cancer Symposium, covering new FDA-approved therapies, dose optimization strategies, and innovative prevention approaches in breast cancer care.

Related Videos
Related Content
herpes zoster or shingles in woman on her waist , cause of varicella zoster virus infections symptoms of itchy ,rash and raised dots on skin and redness with pain and tingling suffering - Image credit: jaojormami | stock.adobe.com
December 23rd 2024

Researchers Evaluate Pain Management Therapy Intervention to Treat Chronic Postherpetic Neuralgia

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

Wooden blocks spelling hemophilia | Image Credit: © lexiconimages - stock.adobe.com
December 23rd 2024

FDA Approves Concizumab-mtci to Prevent, Reduce Bleeding in Patients With Hemophilia A or B

Alexandra Gerlach, Associate Editor
Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes
November 21st 2024

Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes

Christina M. Madison, PharmD, FCCP, AAHIVP
Clearing the Air: The Influence of Vaping on Smoking Cessation
December 23rd 2024

Clearing the Air: The Influence of Vaping on Smoking Cessation

Hannah Elmore, PharmD John Handshaw, PharmD, BCACP Jennifer Stalas, PharmD
Understand the Inextricable Link Between the Pharmacy Revenue Cycle and 340B
December 23rd 2024

Understand the Inextricable Link Between the Pharmacy Revenue Cycle and 340B

Tara Hanuscak, PharmD, MS